Owner Scorecard


← All companies ← INV Manual INVH → ← INSM Pharmaceuticals IONS →

INVA, Innoviva Inc.

Pharmaceuticals consumer brand Cyclical

Innoviva Inc. is a diversified biopharmaceutical company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics, and a portfolio of strategic healthcare assets.

Our Relationship with GSK LABA Collaboration In November 2002, we entered into our LABA Collaboration Agreement with GSK to develop and commercialize once daily products for the treatment of chronic obstructive pulmonary disease ("COPD") and asthma.

Latest annual: FY2025 10-K
INVA · Innoviva Inc.
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2025
$411M
+14.7% YoY · 4% 5-yr CAGR
Vital signs · TTM, with 5-yr average
Revenue $421M 5-yr avg $361M
Operating margin 38.1% 5-yr avg 61.1%
ROIC 12% 5-yr avg 25%
Owner-earnings margin 43% 5-yr avg 60%
Free cash flow margin 43% 5-yr avg 60%

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

What it is
Revenue is led by Royalty (57%) and XACDURO (18%), with 2 more lines behind.
Situation
Cyclical. Margins collapse and recover repeatedly across the record; a single year, good or bad, misstates the through-cycle earning power.
What moves the needle
Operating margin has run about 85% through the cycle, a wide margin for the work it does — whether that reflects a durable edge or one that can fade is what the record weighs. The operating margin has swung widely — from 37% to 96% over the years — so the through-cycle figure carries more than any single year, and the worst year more than the best. Read this kind of business on the pipeline against the patent cliff, and pricing. On its own account, the filing leans hardest on pricing power & competition, set against the numbers in what the filing emphasizes, below.
Is it a good business?
Return on capital has run high across the record (median 44%, above 15% in 8 of 9 years), though buybacks and expensed R&D and brands shrink the capital base, so the figure overstates the underlying economics. The steadier read is owner earnings: roughly 63% of revenue reaches owners as cash, consistently. Whether these returns reflect real pricing power or an accounting artifact is the judgment the 10-K is for.

Every line is arithmetic on the company's filings, shown in full in the sections below.

Where the money comes from

read the 10-K →

Revenue spreads across 6 lines, the largest Royalty at 57%.

Revenue by product line, FY2025
  • Royalty57%$236M
  • XACDURO18%$74M
  • GIAPREZA18%$74M
  • XERAVA6%$24M
  • License And Other Revenue1%$3M
  • ZEVTERA0%$610K

From the segment footnote of the company's own 10-K. Shares are of total revenue; the profit bar shows each segment's share of segment operating profit, before unallocated corporate costs.

II

The record

Ten years of arithmetic, read across the cycle.

The record, 2016–2025

realized figures from each filing · older years to the left
2016’162017’172018’182019’192020’202021’212022’222023’232024’242025’25TTMTTMMar 2026
Income statement
$134M$217M$261M$261M$337M$392M$331M$310M$359M$411M$421MRevenueRevenue
17%15%8%6%4%4%19%32%32%28%28%SG&A / revenueSG&A/rev
1%1%0%0%1%0%13%11%4%7%7%R&D / revenueR&D/rev
$109M$184M$238M$246M$321M$375M$287M$114M$167M$164M$160MOperating incomeOp. inc.
81.6%84.5%91.3%94.4%95.3%95.7%86.6%36.7%46.5%39.8%38.1%Operating marginOp. mgn
$60M$134M$395M$157M$224M$266M$214M$180M$23M$271M$504MNet incomeNet inc.
0%0%21%21%22%24%7%37%17%16%Effective tax rateTax rate
Cash flow & returns
$61M$142M$224M$257M$313M$364M$202M$141M$189M$197M$184MOperating cash flowOp. cash
$14M$14M$14M$14M$14M$14M$16MDepreciationDeprec.
($21M)($16M)($189M)$84M$73M$82M($20M)($44M)$159M($84M)($347M)Working capital & otherWC & other
$278K$0$0$12K$13K$0$67K$411K$270K$1M$2MCapexCapex
0.2%0.0%0.0%0.0%0.0%0.0%0.0%0.1%0.1%0.3%0.4%Capex / revenueCapex/rev
$61M$142M$224M$257M$313M$364M$202M$141M$188M$196M$182MOwner earningsOwner earn.
45.4%65.3%85.6%98.6%93.0%92.8%60.9%45.3%52.5%47.6%43.3%Owner earnings marginOE mgn
$61M$142M$224M$257M$313M$364M$202M$141M$188M$196M$182MFree cash flowFCF
45.4%65.3%85.6%98.6%93.0%92.8%60.9%45.3%52.5%47.6%43.3%Free cash flow marginFCF mgn
$960K$281K$80K$11K$0$0$0Dividends paidDiv. paid
$78M$98M$0$0$0$394M$9M$76M$15M$5MBuybacksBuybacks
44%71%50%47%37%48%27%11%15%12%ROICROIC
257%50%42%64%38%27%3%23%38%Return on equityROE
257%50%42%64%38%Retained to equityRetained/eq
Balance sheet
$118M$73M$62M$278M$246M$202M$291M$194M$305M$551M$603MCash & investmentsCash+inv
$0$9M$14M$20M$35M$34MReceivablesReceiv.
$0$56M$41M$34M$39M$39MInventoryInvent.
$128K$601K$11K$10K$66K$27K$3M$7M$2M$5M$7MAccounts payablePayables
($27K)$62M$48M$52M$69M$66MOperating working capitalOper. WC
$198M$200M$199M$431M$342M$314M$444M$344M$554M$728M$773MCurrent assetsCur. assets
$20M$35M$6M$5M$6M$6M$135M$38M$236M$50M$37MCurrent liabilitiesCur. liab.
9.9×5.8×34.9×80.3×56.0×54.0×3.3×9.0×2.3×14.6×21.1×Current ratioCurr. ratio
$0$27M$18M$18M$18M$18MGoodwillGoodwill
$379M$367M$548M$725M$1000M$926M$1.2B$1.2B$1.3B$1.6B$1.8BTotal assetsAssets
$716M$574M$383M$377M$386M$395M$540M$446M$448M$258M$401MTotal debtDebt
$598M$501M$320M$99M$139M$193M$249M$253M$143M($293M)($203M)Net debt / (cash)Net debt
2.1×4.2×9.9×13.2×17.5×19.7×18.2×5.9×7.5×9.8×9.2×Interest coverageInt. cov.
($353M)($243M)$154M$313M$540M$415M$566M$675M$691M$1.2B$1.3BShareholders’ equityEquity
6.2%4.5%1.2%0.8%0.5%0.5%2.2%1.9%1.8%2.3%2.3%Stock comp / revenueSBC/rev
Per share
123M120M113M113M114M94.3M95.2M86.9M74.2M84.8M84.8MShares out (diluted)Shares
$1.08$1.81$2.30$2.30$2.97$4.16$3.48$3.57$4.84$4.85$4.96Revenue / shareRev/sh
$0.48$1.12$3.48$1.39$1.98$2.82$2.25$2.07$0.32$3.20$5.94EPS (diluted)EPS
$0.49$1.18$1.97$2.27$2.76$3.86$2.12$1.62$2.54$2.31$2.14Owner earnings / shareOE/sh
$0.49$1.18$1.97$2.27$2.76$3.86$2.12$1.62$2.54$2.31$2.14Free cash flow / shareFCF/sh
$0.01$0.00$0.00$0.00$0.00$0.00$0.00Dividends / shareDiv/sh
$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.01$0.02Cap. spending / shareCapex/sh
$-2.86$-2.03$1.35$2.76$4.75$4.40$5.94$7.77$9.32$13.84$15.81Book value / shareBVPS
Per-share growththe realized rate an owner's share compounded
9-yr5-yr
Revenue / share+18.1%/yr+10.3%/yr
Owner earnings / share+18.7%/yr−3.5%/yr
EPS+23.4%/yr+10.1%/yr
Capital spending / share+21.8%/yr+159.0%/yr
Book value / share+23.8%/yr

The record, charted

FY2016–2025

Each measure over its full record; the current point and the worst year marked.

Share count
85Mpeak FY2016
ROIC
15%low FY2023

Owner earnings vs. net income

Owner earningsNet income

The accountant's number, and the cash an owner can take; the gap is the tell.

$196Mowner earningsvs.$271Mnet incomelow FY2016

Where the cash went

ReinvestBuybacksDividendsAcquisitionsRetained

Each year's operating cash, by what management did with it: the mix, and how it drifts.

FY2016FY2025

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business reported $271M of profit but $196M of owner earnings: $75M less than the profit line, taken out by capital spending and the timing of cash.

Reported net income$271M
Owner earnings$196M · 48% of revenue
FY2025FY2024FY2023FY2022FY2021
Reported net income$271M$23M$180M$214M$266M
Depreciation & amortizationnon-cash charge added back+$14M
Stock-based compensationreal costnon-cash, but a real cost+$9M+$6M+$6M+$7M+$2M
Working capital & othertiming of cash in and out, other non-cash items−$84M+$159M−$44M−$20M+$82M
Cash from operations$197M$189M$141M$202M$364M
Capital expenditurecash put back in to keep running and to grow−$1M−$270K−$411K−$67K
Owner earnings$196M$188M$141M$202M$364M
Owner-earnings marginowner earnings ÷ revenue48%53%45%61%93%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $9M), owner earnings is nearer $186M.

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2025 10-K · source on SEC EDGAR →

Will it survive?

  • Comfortable
    Operating income $164M ÷ interest expense $17M
    What this means

    Operating profit covers interest with the kind of margin Graham wanted for a defensive holding. Necessary, not sufficient, it says solvent, not cheap.

  • Net cash
    Cash $551M + ST investments $196M − debt $471M
    What this means

    Cash and short-term investments exceed every dollar of debt by $276M, on net the company owes nothing, and can act from strength when others can't. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Not enough data
    What this means

    The filing data didn't include the inputs for this check.

Is it a good business?

  • Very high (≥25%) through the cycle
    9-yr median, range 11%–71%; 12% latest = NOPAT $136M ÷ invested capital $1.1B
    Industry peers: median -68%
    What this means

    The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 9 years (it ran 12% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.

  • High through the cycle
    10-yr median margin, range 45%–99%; latest $196M = operating cash $197M − maintenance capex $1M
    Industry peers: median -48%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 48% of revenue this year, a 61% median across 10 years. Treating stock comp as the real expense it is (less $9M of SBC) leaves $186M.

  • Mostly cash-backed
    Cash from ops $197M ÷ net income $271M
    What this means

    How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.

How is the cash used?

  • Reinvests most of it
    Dividends + buybacks $5M ÷ Owner Earnings $196M
    What this means

    Of $196M Owner Earnings, $5M (2%) went back to shareholders, $0 dividends, $5M buybacks. But the buybacks barely exceed stock issued to employees ($9M SBC), net of dilution, little was truly returned. Returning most of it is the mark of a mature business with little left to reinvest at a high return; reinvesting most could mean a long runway, or empire-building. The split doesn't say which; the return earned on it (see ROIC) does.

  • Investing or harvesting? 0.08×
    Harvesting
    Capex $1M ÷ depreciation $14M
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

Graham’s defensive tests · 3 of 6 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size Miss
    Revenue ≥ $2B · $411M
    What this means

    Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.

  • Strong liquidity Pass
    Current ratio ≥ 2× · 14.64×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Pass
    Debt ≤ working capital · $471M vs $678M WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Earnings stability Pass
    A profit every year (10-yr record) · no losses
    What this means

    Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.

  • Dividend record Miss
    Uninterrupted dividends · 4 of 10 yrs
    What this means

    An unbroken dividend was Graham's mark of durability. He wanted twenty years; the filings show about ten, and a single suspension breaks the streak. Non-payers, many fine modern compounders, fall outside his defensive net by design.

  • Earnings growth Miss
    Earnings +33% over the record · −19%
    What this means

    At least a third more earnings than a decade ago, averaging three years at each end. Net income (not per-share), so stock splits don't distort it, buybacks and dilution show up in the share-count line instead.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $2.14/share (latest year $3.67), the averaged base the calculator's gate runs on, and book value is $15.89/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2016–2025

Whether the record’s returns held, and what the capital reinvested earned.

  • Profitable years 10 of 10
    What this means

    Never lost money over the record, the earnings stability Graham insisted on.

  • Return on capital ≥ 15% 8 of 10 yrs
    What this means

    A moat shows up as a high return on invested capital that holds year after year, not one good vintage.

  • Operating margin 86% → 41% (3-yr avg ends)

    In the filing’s words The filing attributes gains to higher prices but names price competition too — and the margin slipped, so the pressure is winning here.

    What this means

    Through the cycle the operating margin slipped — about 86% early to 41% lately, median 85% — competition or costs are biting in.

  • Reinvestment, incremental ROIC −11%
    What this means

    Reinvested capital came back at a negative incremental return over this window — the invested base grew while operating profit did not. The filings show where it went.

  • Owner earnings growth +7%/yr
    What this means

    Owner earnings grew about 7% a year over the record.

  • Worst year 2023 · 36.7% op. margin
    What this means

    Stayed profitable even in its hardest year, the resilience that survives recessions.

  • Share count −4.1%/yr
    What this means

    The share count is shrinking, buybacks are quietly growing your slice of the business.

  • Dividend record paid
    What this means

    Paid a dividend in 4 of the years on record.

  • How management talks about it Owner’s terms
    What this means

    The record and the register agree: capital is compounding and the filing reasons in an owner’s terms — per-share value, return on capital, the long term — not a promoter’s.

Does AI threaten the moat?

Low contestability

The moat is physical, regulated or balance-sheet-funded, the kind AI cuts costs within but does not contest.

In its own filing Named as a competitive risk

Its FY2025 10-K names artificial intelligence as a competitive threat.

“AI technologies offer numerous potential benefits, such as creating or increasing operational efficiencies, and we expect the use of AI and generative AI by us, third parties on our behalf, and other market actors, including our competitors, to increase.”

AI is unlikely to contest a moat that is physical, regulated or balance-sheet-funded; here it reads more as a cost tool than a threat, and the company is using it that way.

Read from the filing's own risk factors, paired with the industry's structure under its SIC code; the durability is read above, the price below.

All figures as filed; the source filing is linked above.

Current Position

as of the latest quarter, Mar 31, 2026

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$773M
  • Cash & short-term investments$603M
  • Receivables$34M
  • Inventory$39M
  • Other current assets$96M
Current liabilities$37M
  • Accounts payable$7M
  • Other current liabilities$30M
Current ratio21.13×all current assets ÷ what's due · Graham looked for 2×
Quick ratio20.07×stricter: inventory excluded
Cash ratio16.50×strictest: cash alone against what's due
Working capital$736Mthe cushion left after near-term bills
Revenue, latest quarter vs. a year ago+10.6%the freshest read on whether the business is still growing
Current ratio, recent quarters12.7× → 21.1×
Deeper floors
Tangible book value$1.1Bequity stripped of goodwill & intangibles
Debt incl. operating leases$269M$11M of it operating leases
Deferred revenue$4Mcustomer cash collected before delivery; operating float

From the company's latest filing.

How the cash was used, 2016–2025

Over the record, the business generated $2.1B of operating cash; how management split it reads as a balanced allocator, splitting cash between the business, owners, and the balance sheet.

  • Reinvested$2M · 0%
  • Dividends$1M · 0%
  • Buybacks$673M · 32%
  • Retained (debt / cash)$1.4B · 68%
  • Returned to owners$675M

    32% of the owner earnings the business produced over the span, $1M as dividends and $673M as buybacks.

  • Source of fundingOperating cash

    Operating cash covered reinvestment and returns; over the span debt fell $315M and cash and short-term investments rose $485M.

  • Average price paid for buybacks

    Buybacks ran $673M over the span, but a stock split in the window left the reported buyback-share counts on a basis the diluted-share count doesn't match, so a comparable average price can't be drawn.

  • Net change in share count−31.1%

    The diluted count fell from 123M to 85M, so the buybacks outran the stock issued to staff.

  • Dividend record$0.00/sh

    Paid in 4 of the years on record. It was cut at least once along the way.

  • Return on what it retained3%

    Of the earnings it kept rather than paid out ($1.2B over the span), annual owner earnings (first three years vs last three) grew $33M, so each retained $1 added about 0.03 of yearly owner earnings. Buffett's test, run on owner earnings instead of market value.

Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.

Management, ownership & pay

read the proxy →

From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.

Fiscal yearChief executivePay, as filed“Actually paid”Owner earnings
2021Mr. Raifeld$1.3M$1.2M$364M
2022Mr. Raifeld$1.8M$7,127$202M
2023Mr. Raifeld$869k$1.1M$141M
2024Mr. Raifeld$2.7M$3.1M$188M
2025Mr. Raifeld$5.4M$6.1M$196M

Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years.

  • Insider ownership2%

    The stake all directors and executive officers hold together, per the 2026 proxy: skin in the game, the first thing Munger reads.

  • Stock-based compensation$9M

    The slice of the business handed to employees in shares this year, 2% of revenue, equal to 6% of operating profit. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

Inverting the record

Invert: instead of why Innoviva Inc. is a good business, the question is what would make owning it a mistake, and whether those marks are in the record. Disconfirming tests across 2016–2025.

1 of the 4 tests turned up something to look into; the other 3 came back clean.

  • Look hereIs it less profitable than it was?48.5% vs 65.4%

    The owner-earnings margin averaged 65.4% early in the record and 48.5% across the last three years, and the latest year has not recovered. Ask the filing whether that is a structural drift or a cyclical trough — price, mix, cost, or a competitor — and whether it is permanent.

And these came back clean
  • Did the share count rise anyway?
  • Did debt outgrow the business?
  • Did reported profit become cash?

Each test is read from the filings and is noisy alone; a flag can mark a cyclical trough or a year of heavy investment as easily as a problem. The filing says which.

What an owner would ask, FY2025

read the 10-K →
  • Which reported numbers are a judgment call?
    Management names Revenue recognition as critical estimates

    each rests partly on management's judgment; the filing's note sets out the assumptionsverify →

The questions the record and the charts do not answer on their own; each carries the figure and the place to look.

Peers, Pharmaceuticals

The same industry, side by side on owner economics. Each figure is a through-cycle median, so a peak or trough year can’t distort it; the group median at the foot is the line to read each against.

CompanyRevenueGross marginOp. marginROICOwner earn. margin
TVTXTravere Therapeutics$491M97%-83.6%-35%-20%
NATRNature's Sunshine Products Inc.$480M73%4.3%12%4%
ZLABZai Lab Limited$457M65%-338.0%-103%-281%
INVAInnoviva Inc.$411M85.6%44%63%
ARDXArdelyx Inc.$407M87%-138.7%-82%-232%
ESPREsperion Therapeutics Inc.$403M-62.8%-48%
ARQTArcutis Biotherapeutics Inc.$376M90%-234.9%-56%-236%
AVIRAtea Pharmaceuticals Inc.$351M-51.5%-80%-38%
Group median-73.2%-56%-43%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

Type today's close and see the owner-earnings growth you'd have to believe to justify it, beside what Innoviva Inc. has delivered.

$

Through the cycle, Innoviva Inc. earns about $259M on its 63.1% median owner-earnings margin. This year’s 47.6% margin runs below that; the reported figure may understate a lean year. Normalize, below, values the price on that through-cycle figure rather than the latest year.

Base

The assumptions

9.0% = the 4.55% 10-year Treasury (Jul 15, 2026) + 4.45 points of equity premium. The rate you require is yours to set.

Enter a price above to run it.

Implied by the price
Owner-earnings growth · ’21→’25−9%/yr
Owner-earnings growth · ’16→’25+7%/yr
Owner-earnings yield
P/E (3-yr earnings ’23–’25)
P/B
Graham’s price gate

Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.

Against a high-grade bond: Graham’s yardstick bond yield%

Prefilled with the 10-year Treasury (4.55%, as of Jul 15, 2026). Edit it for today’s exact figure, or a AAA corporate yield.

Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.

Free cash flow $182M on 74M shares outstanding, per the 10-Q cover, as of 2026-04-30; net cash $203M. The if-converted diluted count is 85M, 15% above the shares outstanding: the dilution overhang (convertibles, options) a buyer inherits. The base is the latest year by default; Normalize values it on the through-cycle median owner-earnings margin (to avoid paying on a peak year). Net of stock comp treats option pay as the expense it is. Capex ($2M) runs well above depreciation ($16M), so this is a build-out; Steady-state swaps total capex for maintenance (≈ depreciation), lifting the base to about $182M, the cash it would throw off if it stopped expanding. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.

Cite: Owner Scorecard, "Innoviva Inc. (INVA), the owner's record," https://ownerscorecard.com/c/INVA, data as of 2026-07-09.

Manual order: ← INV its page in the Manual INVH →

Industry order: ← INSM the Pharmaceuticals chapter IONS →